Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Tenderness, Vaccination site erythema, Vaccination site pain, Vaccination site swelling
Clinical narrative: Swelling of the arm and tender; 5 inches down and 4 inches and very tender; Felt burning; Visual disturbance was not blurry just not normal could not focus; tingling-like sensation; little dizzy.; Tightness in chest; Could not breath deeply; Mild chest pain; redness and swelling, 5x4"; redness and swelling, 5x4",; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (Tightness in chest), PERIPHERAL SWELLING (Swelling of the arm and tender), CHEST PAIN (Mild chest pain), VISION BLURRED (Visual disturbance was not blurry just not normal could not focus) and DYSPNOEA (Could not breath deeply) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension since 26-Aug-2008, Hypothyroidism since 15-Jul-2005, Macular degeneration (Retinal bleeding in 2nd eye since 15-DEC-2020), Drug allergy and Retinal bleeding since 15-Dec-2020. Concomitant products included METOPROLOL SUCCINATE (METOPROLOL [METOPROLOL SUCCINATE]) from 09-Sep-2008 to an unknown date for Hypertension, LEVOTHYROXINE from 02-Sep-2005 to an unknown date for Hypothyroidism, RANIBIZUMAB (LUCENTIS) from 09-Nov-2017 to an unknown date for Macular degeneration, VITAMIN D3 from 30-Sep-2019 to an unknown date for Nutritional supplement, ASCORBIC ACID, TOCOPHERYL ACETATE, XANTOFYL, ZEAXANTHIN, ZINC (AREDS) from 09-Oct-2017 to an unknown date for Vitamin supplementation.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced CHEST DISCOMFORT (Tightness in chest), CHEST PAIN (Mild chest pain), DYSPNOEA (Could not breath deeply), DIZZINESS (little dizzy.), VACCINATION SITE ERYTHEMA (redness and swelling, 5x4") and VACCINATION SITE SWELLING (redness and swelling, 5x4",). On 27-Jan-2021 at 9:15 AM, the patient experienced VISION BLURRED (Visual disturbance was not blurry just not normal could not focus) and PARAESTHESIA (tingling-like sensation). On 28-Jan-2021, the patient experienced PERIPHERAL SWELLING (Swelling of the arm and tender), TENDERNESS (5 inches down and 4 inches and very tender) and VACCINATION SITE PAIN (Felt burning). On 27-Jan-2021, VISION BLURRED (Visual disturbance was not blurry just not normal could not focus), DYSPNOEA (Could not breath deeply), PARAESTHESIA (tingling-like sensation) and DIZZINESS (little dizzy.) had resolved. On 31-Jan-2021, VACCINATION SITE PAIN (Felt burning) had resolved. At the time of the report, CHEST DISCOMFORT (Tightness in chest), PERIPHERAL SWELLING (Swelling of the arm and tender) and TENDERNESS (5 inches down and 4 inches and very tender) outcome was unknown and CHEST PAIN (Mild chest pain), VACCINATION SITE ERYTHEMA (redness and swelling, 5x4") and VACCINATION SITE SWELLING (redness and swelling, 5x4",) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 18-Apr-2021: Updated patient details, other relevant history AMD,  vaccination information. Added concomitant products, added new events dizziness, injection site reactions; erythema, swelling, pain On 20-Apr-2021: Updated reporter details.